Urinary CXCL16 and endostatin can reflect the degree of interstitial fibrosis and tubular atrophy, which is a risk factor for poor renal outcome in DN patients, and act as biomarkers among these patients [89]. The gene discussed is CXCL16; the disease is liver dysplastic nodule.